Equities research analysts at Evercore ISI started coverage on shares of Organovo Holdings Inc. (NASDAQ:ONVO) in a note issued to investors on Monday. The firm set a “buy” rating and a $4.50 price target on the stock. Evercore ISI’s price target indicates a potential upside of 47.06% from the stock’s current price.

Separately, Zacks Investment Research raised Organovo Holdings from a “hold” rating to a “buy” rating and set a $3.25 price objective on the stock in a research note on Wednesday, November 9th.

Shares of Organovo Holdings (NASDAQ:ONVO) opened at 3.06 on Monday. The firm has a 50 day moving average price of $3.15 and a 200-day moving average price of $3.56. Organovo Holdings has a 12 month low of $1.60 and a 12 month high of $4.99.

Organovo Holdings (NASDAQ:ONVO) last issued its quarterly earnings data on Thursday, November 3rd. The company reported ($0.10) EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.11) by $0.01. The business had revenue of $1.38 million for the quarter. Organovo Holdings had a negative return on equity of 62.11% and a negative net margin of 1,178.36%. On average, equities research analysts predict that Organovo Holdings will post ($0.39) earnings per share for the current fiscal year.

ILLEGAL ACTIVITY WARNING: “Organovo Holdings Inc. (ONVO) Now Covered by Evercore ISI” was published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this piece of content on another domain, it was stolen and republished in violation of U.S. and international copyright laws. The original version of this piece of content can be accessed at https://www.thecerbatgem.com/2016/11/30/organovo-holdings-inc-onvo-now-covered-by-evercore-isi.html.

Hedge funds have recently modified their holdings of the company. SG Americas Securities LLC increased its stake in shares of Organovo Holdings by 72.6% in the third quarter. SG Americas Securities LLC now owns 34,953 shares of the company’s stock valued at $132,000 after buying an additional 14,706 shares during the last quarter. Sigma Planning Corp increased its stake in shares of Organovo Holdings by 60.8% in the third quarter. Sigma Planning Corp now owns 35,690 shares of the company’s stock valued at $135,000 after buying an additional 13,500 shares during the last quarter. BlackRock Advisors LLC increased its stake in shares of Organovo Holdings by 20.3% in the second quarter. BlackRock Advisors LLC now owns 39,509 shares of the company’s stock valued at $147,000 after buying an additional 6,670 shares during the last quarter. Quantitative Investment Management LLC increased its stake in shares of Organovo Holdings by 142.4% in the third quarter. Quantitative Investment Management LLC now owns 41,700 shares of the company’s stock valued at $158,000 after buying an additional 24,500 shares during the last quarter. Finally, Cue Financial Group Inc. increased its stake in shares of Organovo Holdings by 4.8% in the third quarter. Cue Financial Group Inc. now owns 44,000 shares of the company’s stock valued at $167,000 after buying an additional 2,000 shares during the last quarter. 18.44% of the stock is currently owned by institutional investors and hedge funds.

Organovo Holdings Company Profile

5 Day Chart for NASDAQ:ONVO

Receive News & Stock Ratings for Organovo Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organovo Holdings Inc. and related stocks with our FREE daily email newsletter.